Get the Stockscreener App
3.39
0.87%
-0.05
Briacell Therapeutics Corp stock is traded at $3.39, with a volume of 52,378.
It is down -0.87% in the last 24 hours and down -8.58% over the past month.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
See More
Previous Close:
$3.44
Open:
$3.46
24h Volume:
52,378
Relative Volume:
0.27
Market Cap:
$29.58M
Revenue:
-
Net Income/Loss:
$-30.98M
P/E Ratio:
-0.2776
EPS:
-12.2116
Net Cash Flow:
$-31.84M
1W Performance:
+0.59%
1M Performance:
-8.58%
6M Performance:
-14.11%
1Y Performance:
+360.81%
1-Day Range:
$3.3891
$3.50
1-Week Range:
$3.36
$3.58
52-Week Range:
$0.6311
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.40 | 29.93M | 0 | -30.98M | -31.84M | -12.21 |
VRTX
Vertex Pharmaceuticals Inc
|
515.76 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.65 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.87 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.83 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.63 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
BriaCell Therapeutics Corp (TSX:BCT) Shares Decline as Biotech Uncertainty, Funding Risks and Clinical Execution Concerns Pressure Sentiment - kalkine.ca
Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXL - TradingView
Briacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BriaCell Therapeutics Corp. (BCTXZ) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Briacell Therapeutics Corp (BCTX) Stock News Today - TradingKey
BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer - Investing News Network
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - The Manila Times
FDA clearance lets BriaCell test personalized prostate immunotherapy - Stock Titan
BriaCell Therapeutics (BCTX) Rises 3.86% to $3.5 as Immuno-Oncology Interest BuildsAnalyst Downgrade Signals - dars.gov.et
Why Did BriaCell Therapeutics Corp. (TSX:BCT) Stock Fall 5.49% on 31 July 2026? - kalkine.ca
BriaCell Therapeutics Warrant (BCTXZ) Holds at $0.09 as Long-Dated Biotech Option Trades FlatUp Down Volume - dars.gov.et
BriaCell Therapeutics Corp Revenue Breakdown – TSX:BCT - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – BOATS:BCTXL - TradingView
Briacell Therapeutics Corp (BCTX) Institutional Confidence - TradingKey
Briacell Therapeutics Corp (BCTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.338|Chg%:-0.022 - TradingKey
Briacell Therapeutics Corp (BCTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BriaCell Therapeutics Market Sentiment - Benzinga España
Briacell Therapeutics Corp (BCTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Briacell Therapeutics Corp (BCTX) Income Statement - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.525|Chg%:-0.055 - TradingKey
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXL - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXZ - TradingView
BriaCell Therapeutics Corp Revenue Breakdown – MUN:8BT - TradingView
BCTX|Briacell Therapeutics Corp|Price:3.580|Chg%:-0.140 - TradingKey
BriaCell Therapeutics Warrant (BCTXL) Holds Steady at $0.89 as Support and Resistance Levels Come into FocusHidden Order - dars.gov.et
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Why Briacell Therapeutics Corp stock is sliding today - Wealth Awesome
What's Going On With Briacell Therapeutics Corp Stock Monday? - Wealth Awesome
BriaCell Therapeutics Warrants (BCTXZ) Spike 9.32% as Shares Test Key Support at $0.10Analyst Upgrade Stocks - dars.gov.et
Is CRA International’s New Bria-IMT Role Quietly Redefining Its Healthcare Moat and Pricing Power (CRAI)? - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site - GuruFocus
What Does BriaCell's Latest Offering Mean for Shareholders - Kavout | AI
Briacell Therapeutics Corp. - Menafn
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Therapeutics Corp. - Baystreet.ca
Why Briacell Therapeutics Corp stock is skyrocketing today - Wealth Awesome
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer - marketscreener.com
BriaCell Opens First Canadian SiteSunnybrookfor Pivotal Phase 3 Trial in Metastatic Breast Cancer - The Manila Times
Stocks In Play - Baystreet.ca
BriaCell Taps FUJIFILM for Bria-IMT Manufacturing - Contract Pharma
BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufact - GuruFocus
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™ - The Manila Times
BriaCell Therapeutics Corp.: BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT - FinanzNachrichten.de
What's Going On With Briacell Therapeutics Corp Stock Tuesday? - Wealth Awesome
BriaCell Therapeutics Corp. Warrants (BCTXZ) Hold Steady at $0.1 Amid Quiet TradingTotal Put Call - dars.gov.et
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.00%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):